Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab for Chronic Cough with Eosinophilic Airways Diseases
NCT04765722Phase 4Completed
- Sponsor
- McMaster University
- Start
- Dec 2021
- Primary completion
- Nov 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of mepolizumab in chronic cough, eosinophilic asthma (EA), eosinophilic bronchitis (EB), sponsored by McMaster University. Started Dec 2021; status: completed.
02
Drugs
mepolizumab
03
Conditions
chronic cougheosinophilic asthma (EA)eosinophilic bronchitis (EB)
Beyond the preview
Go deeper on NCT04765722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765722.